000 | 01854 a2200493 4500 | ||
---|---|---|---|
005 | 20250516042520.0 | ||
264 | 0 | _c20111227 | |
008 | 201112s 0 0 eng d | ||
022 | _a1568-7856 | ||
024 | 7 |
_a10.1016/j.dnarep.2011.05.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSemlitsch, Michaela | |
245 | 0 | 0 |
_aATM protects against oxidative stress induced by oxidized low-density lipoprotein. _h[electronic resource] |
260 |
_bDNA repair _cAug 2011 |
||
300 |
_a848-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 | _aAtaxia Telangiectasia Mutated Proteins |
650 | 0 | 4 |
_aCell Cycle Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCell Survival |
650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xmetabolism |
650 | 0 | 4 | _aDNA Breaks, Double-Stranded |
650 | 0 | 4 |
_aDNA-Binding Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
650 | 0 | 4 |
_aFibroblasts _xdrug effects |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLipoproteins, LDL _xmetabolism |
650 | 0 | 4 | _aOxidative Stress |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 |
_aThiocarbamates _xpharmacology |
650 | 0 | 4 |
_aTumor Suppressor Proteins _xantagonists & inhibitors |
700 | 1 | _aShackelford, Rodney E | |
700 | 1 | _aZirkl, Sandra | |
700 | 1 | _aSattler, Wolfgang | |
700 | 1 | _aMalle, Ernst | |
773 | 0 |
_tDNA repair _gvol. 10 _gno. 8 _gp. 848-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.dnarep.2011.05.004 _zAvailable from publisher's website |
999 |
_c20924773 _d20924773 |